Zurich, V8CIK 15954304 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
16 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Revolution Medicines Inc | 7.60M | $605.43M | 58.5% | 0 | Held |
| 2 | Tyra Biosciences Inc | 4.06M | $106.63M | 10.3% | 0 | Held |
| 3 | Tango Therapeutics Inc | 7.27M | $64.38M | 6.2% | +1.73M | Added |
| 4 | Oric Pharmaceuticals Inc |
| 7.16M |
| $58.59M |
| 5.7% |
| 0 |
| Held |
| 5 | Relay Therapeutics Inc | 4.70M | $39.77M | 3.8% | +855.1K | Added |
| 6 | Zymeworks Inc | 1.11M | $29.33M | 2.8% | 0 | Held |
| 7 | Alumis Inc | 2.92M | $28.46M | 2.8% | 0 | Held |
| 8 | Kymera Therapeutics Inc | 278.9K | $21.70M | 2.1% | −62.0K | Reduced |
| 9 | Engene Holdings Inc | 2.12M | $19.19M | 1.9% | +2.12M | New |
| 10 | Mersana Therapeutics Inc | 482.7K | $13.96M | 1.3% | 0 | Held |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio